ASX - By Stock
|
BB1 |
Re:
The float
|
|
showie
|
91 |
51K |
10 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
91
|
51K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Meeting - Chairman's Address & Presentation
|
|
showie
|
82 |
26K |
3 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
82
|
26K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Meeting - Chairman's Address & Presentation
|
|
showie
|
82 |
26K |
2 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
82
|
26K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Meeting - Chairman's Address & Presentation
|
|
showie
|
82 |
26K |
1 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
82
|
26K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Appendix 4E and Annual Report
|
|
showie
|
60 |
17K |
7 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
60
|
17K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Second Supplementary Scheme Booklet
|
|
showie
|
255 |
71K |
2 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
255
|
71K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Why you should vote YES - a professional investor's perspective
|
|
showie
|
208 |
57K |
6 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
208
|
57K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Why you should vote YES - a professional investor's perspective
|
|
showie
|
208 |
57K |
11 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
208
|
57K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Best and Final Confirmation and Bridging Loan
|
|
showie
|
242 |
67K |
13 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
242
|
67K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Best and Final Confirmation and Bridging Loan
|
|
showie
|
242 |
67K |
1 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
242
|
67K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Best and Final Confirmation and Bridging Loan
|
|
showie
|
242 |
67K |
6 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
242
|
67K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
VOTE NO. AWAIT "BEST & FINAL" DECLARATION
|
|
showie
|
313 |
91K |
6 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
313
|
91K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Pfizer raises scheme consideration to A$0.208 per share
|
|
showie
|
101 |
31K |
9 |
07/08/22 |
07/08/22 |
ASX - By Stock
|
101
|
31K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Is this the start of the auction?
|
|
showie
|
60 |
20K |
10 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
60
|
20K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
HOW TO VOTE
|
|
showie
|
123 |
37K |
22 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
123
|
37K
|
22
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
showie
|
126 |
37K |
15 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
37K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
showie
|
132 |
47K |
6 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
132
|
47K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
showie
|
425 |
129K |
28 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
425
|
129K
|
28
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
showie
|
377 |
145K |
0 |
19/06/22 |
19/06/22 |
ASX - By Stock
|
377
|
145K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
showie
|
466 |
163K |
17 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
466
|
163K
|
17
|
|
ASX - By Stock
|
RAP |
Re:
Vote NO Pfizer offer
|
|
showie
|
555 |
191K |
24 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
555
|
191K
|
24
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
showie
|
98 |
38K |
8 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
98
|
38K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
showie
|
98 |
38K |
12 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
98
|
38K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
Questions for Quarterly
|
|
showie
|
38 |
11K |
0 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
38
|
11K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Shareholder Registry
|
|
showie
|
44 |
13K |
13 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
44
|
13K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
showie
|
687 |
260K |
9 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
260K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
showie
|
687 |
260K |
12 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
260K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
showie
|
687 |
260K |
22 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
260K
|
22
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
showie
|
1.0K |
301K |
3 |
19/03/22 |
19/03/22 |
ASX - By Stock
|
1.0K
|
301K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
showie
|
1.0K |
301K |
2 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
1.0K
|
301K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Raising awareness of ResAppDx and SleepCheck
|
|
showie
|
52 |
13K |
1 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
52
|
13K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Resapphealth 2022
|
|
showie
|
214 |
61K |
1 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
214
|
61K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
showie
|
4.6K |
2.2M |
8 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
4.6K
|
2.2M
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Agreement with Ilara Health to sell ResAppDx in Kenya
|
|
showie
|
224 |
51K |
3 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
224
|
51K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
showie
|
35 |
13K |
4 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
35
|
13K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
showie
|
35 |
13K |
0 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
35
|
13K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp secures firm commitments to raise $5.5 million
|
|
showie
|
66 |
26K |
1 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
66
|
26K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
some competition for RAP
|
|
showie
|
20 |
6.2K |
13 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
20
|
6.2K
|
13
|
|
ASX - By Stock
|
ZYB |
Re:
Class action against the directors
|
|
showie
|
28 |
18K |
0 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
28
|
18K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
showie
|
3.3K |
2.5M |
15 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
3.3K
|
2.5M
|
15
|
|
ASX - By Stock
|
RAP |
Re:
'Skipped a decade': Tele-health to become permanent after success during pandemic
|
|
showie
|
8 |
3.5K |
17 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
8
|
3.5K
|
17
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
showie
|
245 |
66K |
20 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
245
|
66K
|
20
|
|
ASX - By Stock
|
RAP |
Re:
Ann: AstraZeneca to use new ResApp software in clinical study
|
|
showie
|
121 |
38K |
1 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
121
|
38K
|
1
|
|
ASX - By Stock
|
VOR |
Re:
Ann: Proposed Sale of Cybersecurity Business
|
|
showie
|
134 |
34K |
0 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
134
|
34K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Pause in Trading
|
|
showie
|
48 |
11K |
6 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
48
|
11K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Pause in Trading
|
|
showie
|
48 |
11K |
5 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
48
|
11K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
2020 commercialisation
|
|
showie
|
648 |
229K |
26 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
648
|
229K
|
26
|
|
ASX - By Stock
|
RAP |
Re:
2020 commercialisation
|
|
showie
|
648 |
229K |
37 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
648
|
229K
|
37
|
|
ASX - By Stock
|
RAP |
Re:
2020 commercialisation
|
|
showie
|
648 |
229K |
1 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
648
|
229K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: SleepCheck Now Available in 36 Countries
|
|
showie
|
263 |
106K |
1 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
263
|
106K
|
1
|
|